We do it all the time. Meanwhile, at the MAHA summit in Washington, D.C
It was first identified in 1973 by biochemist Loren Pickart, who observed that plasma from younger donors caused older liver tissue to resume more youthful metabolic activity
That means the study met its main goal, but those watching the weight-loss drug race closely had pegged their hopes on an average result for CagriSema of at least 25% weight loss, which would set a new bar for a field thats already been revolutionized by GLP-1 drugs
Mild to moderate pain Protocol: BPC-157: 250mcg twice daily Duration: 4-8 weeks Method: Injectable near pain site or systemic Expected outcome: 40-60% pain reduction Improved function May be sufficient alone Severe or chronic pain Protocol: BPC-157: 500mcg twice daily TB-500: 5-10mg weekly loading for 4-6 weeks, then 2-5mg maintenance Duration: 12-16 weeks minimum Method: Injectable Expected outcome: 50-70% pain reduction Significant functional improvement Better quality of life Multiple pain sites or systemic pain Protocol: BPC-157: 250-500mcg twice daily (systemic injections - abdomen/thighs) TB-500: 5mg weekly Optional: KPV 500mcg daily if inflammation major factor Duration: 12-24 weeks Expected outcome: 40-60% overall pain reduction Improved multiple areas Better mobility Maintenance protocol After initial relief: BPC-157: 250mcg daily OR every other day TB-500: 2-5mg weekly OR biweekly Duration: Ongoing as needed Why maintenance: Prevents pain return Continues healing Safe long-term Use our peptide dosing guide , peptide dosage chart , and how to calculate peptide dosages
The only way to know for sure is to ask your doctor for a blood test
